Loading…

The chemokine CXCL13 is a prognostic marker in clinically isolated syndrome (CIS)

There is increasing recognition of the importance of B lymphocytes in the immunopathogenesis of multiple sclerosis (MS), encouraging the evaluation of B cell-associated biomarkers in the cerebrospinal fluid (CSF). We aimed to evaluate the relevance of the B cell chemoattractant CXCL13 as a prognosti...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2010-08, Vol.5 (8), p.e11986-e11986
Main Authors: Brettschneider, Johannes, Czerwoniak, Anne, Senel, Makbule, Fang, Lubin, Kassubek, Jan, Pinkhardt, Elmar, Lauda, Florian, Kapfer, Tamara, Jesse, Sarah, Lehmensiek, Vera, Ludolph, Albert C, Otto, Markus, Tumani, Hayrettin
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:There is increasing recognition of the importance of B lymphocytes in the immunopathogenesis of multiple sclerosis (MS), encouraging the evaluation of B cell-associated biomarkers in the cerebrospinal fluid (CSF). We aimed to evaluate the relevance of the B cell chemoattractant CXCL13 as a prognostic marker in patients with clinically isolated syndrome (CIS) regarding conversion to MS, and to compare it to Barkhof criteria in magnetic resonance imaging (MRI), oligoclonal bands (OCB) and the polyspecific intrathecal B cell response against measles, rubella and varicella zoster virus (MRZR). CXCL13 was determined in a prospective study over 2 years including 46 patients that remained CIS over follow-up (CIS-CIS), 45 patients that developed MS (CIS-RRMS), and 30 controls using ELISA. CSF CXCL13 was significantly elevated in CIS-RRMS as compared to CIS-CIS and controls (p
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0011986